Nora Navone

Department of Genitourinary Medical Oncology Research, The University of Texas MD Anderson Cancer Center

Affiliated withThe University of Texas MD Anderson Cancer Center

Research Area

Biography

Nora Navone has not added Biography.
If you are Nora Navone and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 3	2020

Other Publications

Article	Year
Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms. The Journal of clinical investigation\| PubMed ID: 18618013	2008
Quantification of mineralized bone response to prostate cancer by noninvasive in vivo microCT and non-destructive ex vivo microCT and DXA in a mouse model. PloS one\| PubMed ID: 20360964	2010
P-TEFb joins the family of cdks in oncology, promotes cell growth of cancer cells. Cell cycle (Georgetown, Tex.)\| PubMed ID: 20703082	2010
Prioritizing genes associated with prostate cancer development. BMC cancer\| PubMed ID: 21044312	2010
Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21343372	2011
Modeling a lethal prostate cancer variant with small-cell carcinoma features. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22156612	2012
Effect of transforming growth factor beta (TGF-β) receptor I kinase inhibitor on prostate cancer bone growth. Bone\| PubMed ID: 22173053	2012
Androgen regulation of 5α-reductase isoenzymes in prostate cancer: implications for prostate cancer prevention. PloS one\| PubMed ID: 22194926	2011
Activation of β-catenin signaling in androgen receptor-negative prostate cancer cells. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 22298898	2012
Mitosis phase enrichment with identification of mitotic centromere-associated kinesin as a therapeutic target in castration-resistant prostate cancer. PloS one\| PubMed ID: 22363599	2012
Constitutive activation of p38 MAPK in tumor cells contributes to osteolytic bone lesions in multiple myeloma. Leukemia\| PubMed ID: 22425892	2012
Hedgehog signaling inhibition by the small molecule smoothened inhibitor GDC-0449 in the bone forming prostate cancer xenograft MDA PCa 118b. The Prostate\| PubMed ID: 22457212	2012
Arachidonic acid metabolism in human prostate cancer. International journal of oncology\| PubMed ID: 22895552	2012
Targeting fibroblast growth factor pathways in prostate cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 24052019	2013
Targeting poly(ADP-ribose) polymerase and the c-Myb-regulated DNA damage response pathway in castration-resistant prostate cancer. Science signaling\| PubMed ID: 24847116	2014
Prostate cancer cell-stromal cell crosstalk via FGFR1 mediates antitumor activity of dovitinib in bone metastases. Science translational medicine\| PubMed ID: 25186177	2014
Targeting the interleukin-11 receptor α in metastatic prostate cancer: A first-in-man study. Cancer\| PubMed ID: 25832466	2015
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation. Oncotarget\| PubMed ID: 26455377	2015
A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions. Biomaterials\| PubMed ID: 26599623	2016
Differentially methylated genes and androgen receptor re-expression in small cell prostate carcinomas. Epigenetics\| PubMed ID: 26890396	2016
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature\| PubMed ID: 28166537	2017
Targeting DNA Damage Response in Prostate Cancer by Inhibiting Androgen Receptor-CDC6-ATR-Chk1 Signaling. Cell reports\| PubMed ID: 28228262	2017
Hemin Conditioning Targets the Vascular and Immunologic Compartments and Restrains Prostate Tumor Development. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 28512172	2017
Targeting the MYCN-PARP-DNA Damage Response Pathway in Neuroendocrine Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 29138344	2018
An Screen Identifies PYGO2 as a Driver for Metastatic Prostate Cancer. Cancer research\| PubMed ID: 29769196	2018
Intravital microscopy of osteolytic progression and therapy response of cancer lesions in the bone. Science translational medicine\| PubMed ID: 30068572	2018
Genome-wide CRISPR screens reveal synthetic lethality of RNASEH2 deficiency and ATR inhibition. Oncogene\| PubMed ID: 30532030	2019
The estrogen receptor variants β2 and β5 induce stem cell characteristics and chemotherapy resistance in prostate cancer through activation of hypoxic signaling. Oncotarget\| PubMed ID: 30555629	2018
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro. Biomaterials\| PubMed ID: 30682644	2019
Oncogenic and osteolytic functions of histone demethylase NO66 in castration-resistant prostate cancer. Oncogene\| PubMed ID: 30858546	2019
ERR1 and PGC1α associated mitochondrial alterations correlate with pan-cancer disparity in African Americans. The Journal of clinical investigation\| PubMed ID: 30920960	2019
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease. Science translational medicine\| PubMed ID: 31142679	2019
Heme Oxygenase-1 Is a Pivotal Modulator of Bone Turnover and Remodeling: Molecular Implications for Prostate Cancer Bone Metastasis. Antioxidants & redox signaling\| PubMed ID: 31861963	2020
A Phase II Study of Cabozantinib and Androgen Ablation in Patients with Hormone-Naïve Metastatic Prostate Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 31941830	2020
HO-1 Interactors Involved in the Colonization of the Bone Niche: Role of ANXA2 in Prostate Cancer Progression. Biomolecules\| PubMed ID: 32197509	2020
Fibroblast growth factors signaling in bone metastasis. Endocrine-related cancer\| PubMed ID: 32369771	2020
The MD Anderson Prostate Cancer Patient-derived Xenograft Series (MDA PCa PDX) Captures the Molecular Landscape of Prostate Cancer and Facilitates Marker-driven Therapy Development. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 32576626	2020
Myxovirus Resistance Protein 1 (MX1), a Novel HO-1 Interactor, Tilts the Balance of Endoplasmic Reticulum Stress towards Pro-Death Events in Prostate Cancer. Biomolecules\| PubMed ID: 32640729	2020